Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities.
The onset of motor learning in rats coincides with exclusive expression of GABAA receptors containing alpha6 and delta subunits in the granule neurons of the cerebellum. This development temporally correlates with the presence of a spontaneously active chloride current through alpha6-containing GABAA receptors, known as tonic inhibition. Here we report that the coexpression of alpha6, beta2, and delta subunits produced receptor-channels which possessed two distinct and separable states of agonist affinity, one exhibiting micromolar and the other nanomolar affinities for GABA. The high-affinity state was associated with a significant level of spontaneous channel activity. Increasing the level of expression or the ratio of beta2 to alpha6 and delta subunits increased the prevalence of the high-affinity state. Comparative studies of alpha6beta2delta, alpha1beta2delta, alpha6beta2gamma2, alpha1beta2gamma2 and alpha4beta2delta receptors under equivalent levels of expression demonstrated that the significant level of spontaneous channel activity is uniquely attributable to alpha6beta2delta receptors. The pharmacology of spontaneous channel activity arising from alpha6beta2delta receptor expression corresponded to that of tonic inhibition. For example, GABAA receptor antagonists, including furosemide, blocked the spontaneous current. Further, the neuroactive steroid 5alpha-THDOC and classical glycine receptor agonists beta-alanine and taurine directly activated alpha6beta2delta receptors with high potency. Specific mutation within the GABA-dependent activation domain (betaY157F) impaired both low- and high-affinity components of GABA agonist activity in alpha6betaY157Fdelta receptors, but did not attenuate the spontaneous current. In comparison, a mutation located between the second and third transmembrane segments of the delta subunit (deltaR287M) significantly diminished the nanomolar component and the spontaneous activity. The possibility that the high affinity state of the alpha6beta2delta receptor modulates the granule neuron activity as well as potential mechanisms affecting its expression are discussed.
Hadley
Stephen H
SH
Department of Molecular Pharmacology and Physiology, College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Amin
Jahanshah
J
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001640:Bicuculline / Q000494:pharmacology; D003437:Crotonates / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000031:analogs & derivatives / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005665:Furosemide / Q000494:pharmacology; D018755:GABA Agonists / Q000494:pharmacology*; D018756:GABA Antagonists / Q000494:pharmacology; D058785:GABA-A Receptor Agonists; D007093:Imidazoles / Q000494:pharmacology; D008845:Microinjections; D009154:Mutation; D009433:Neural Inhibition / Q000187:drug effects*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D009865:Oocytes; D010852:Picrotoxin / Q000031:analogs & derivatives / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology; D051381:Rats; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism; D054830:Sesterterpenes; D013654:Taurine / Q000494:pharmacology; D014982:Xenopus laevis; D015032:Zinc / Q000494:pharmacology; D015091:beta-Alanine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D001640:Bicuculline; D003437:Crotonates; D003900:Desoxycorticosterone; D005665:Furosemide; D018755:GABA Agonists; D018756:GABA Antagonists; D058785:GABA-A Receptor Agonists; D007093:Imidazoles; D010852:Picrotoxin; D011724:Pyridazines; D011963:Receptors, GABA-A; D054830:Sesterterpenes; D013654:Taurine; D015032:Zinc; D015091:beta-Alanine; D005680:gamma-Aminobutyric Acid; C546173:Gabra6 protein, rat; C502185:Gabrb2 protein, rat; C055331:4-aminocrotonic acid; C009413:tetrahydrodeoxycorticosterone; C049853:gabazine; C022961:picrotoxinin; C005954:imidazoleacetic acid